The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Mitochondrial localization of DJ‐1 leads to enhanced neuroprotection
Open accessAbstract
Mutations in DJ‐1 (PARK7) cause recessively inherited Parkinson's disease. DJ‐1 is a multifunctional protein with antioxidant and transcription modulatory activity. Its localization in cytoplasm, mitochondria, and nucleus is recognized, but the relevance of this subcellular compartmentalization to its cytoprotective activity is not fully understood. Here we report that under basal conditions DJ‐1 is present mostly in the cytoplasm and to a lesser extent in mitochondria and nucleus of dopaminergic neuroblastoma SK‐N‐BE(2)C cells. Upon oxidant challenge, more DJ‐1 translocates to mitochondria within 3 hr and subsequently to the nucleus by 12 hr. The predominant DJ‐1 species in both mitochondria and nucleus is a dimer believed to be the functional form. Mutating cysteine 106, 53, or 46 had no impact on the translocation of DJ‐1 to mitochondria. To study the relative neuroprotective activity of DJ‐1 in mitochondria and nucleus, DJ‐1 cDNA constructs fused to the appropriate localization signal were transfected into cells. Compared with 30% protection against oxidant‐induced cell death in wild‐type DJ‐1‐transfected cells, mitochondrial targeting of DJ‐1 provided a significantly stronger (55%) cytoprotection based on lactate dehydrogenase release. Nuclear targeting of DJ‐1 preserved cells equally as well as the wild‐type protein. These observations suggest that the time frame for the translocation of DJ‐1 from the cytoplasm to mitochondria and to the nucleus following oxidative stress is quite different and that dimerized DJ‐1 in mitochondria is functional as an antioxidant not related to cysteine modification. These findings further highlight the multifaceted functions of DJ‐1 as a cytoprotector in different cellular compartments. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DJ-1 exposed to oxidative stress undergoes oxidation of Cysteine106 and translocates from cytoplasm to mitochondria or to the nucleus (Junn et al. 2009).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Junn et al. 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canet-Aviles, R., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,115
DJ‐1 has a role in antioxidative stress to prevent cell death
Taira, T., Saito, Y., Niki, T., Iguchi‐Ariga, S. M. M., Takahashi, K., & Ariga, H. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400074 · Cited by 866
Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S. P., Mount, M. P., Pownall, S., Wakeham, A. C., You-Ten, A. J., Kalia, S. K., Horne, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501282102 · Cited by 711
Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario
Chipuk, J. E., Bouchier-Hayes, L., & Green, D. R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401963 · Cited by 631
DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation
Shendelman, S., Jonason, A. S., Martinat, C., Leete, T., & Abeliovich, A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020362 · Cited by 610
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
Bandopadhyay, R. (2004) · Brain · doi:10.1093/brain/awh054 · Cited by 475
DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism
Bonifati, V., Rizzu, P., Squitieri, F., Krieger, E., Vanacore, N., Swieten, J. C. V., Brice, A., van Duijn, C. M., Oostra, B. A., Meco, G., et al. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0108-0 · Cited by 427
PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases
Kotaja, N., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5222-5234.2002 · Cited by 426
Zhang, L., Shimoji, M., Thomas, B., Moore, D. J., Yu, S.-W., Marupudi, N. I., Torp, R., Torgner, I. A., Ottersen, O. P., Dawson, T. M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi211 · Cited by 425
PARK7, a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, on Chromosome 1p36
van Duijn, C. M., Dekker, M. C. J., Bonifati, V., Galjaard, R. H., Houwing‐Duistermaat, J. J., Snijders, P. J. L. M., Testers, L., Breedveld, G. J., Horstink, M. W. I. M., Sandkuijl, L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/322996 · Cited by 385
Flagged first, then by citations
Cited by
Sorted by citations
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Self-citationCysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery
Paulsen, C. E., & Carroll, K. S. (2013) · Chemical Reviews · doi:10.1021/cr300163e · Cited by 1,313
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S., & Chesselet, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 953
Oxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878
Mitochondrial Defects and Oxidative Stress in Alzheimer Disease and Parkinson Disease
Yan, M. H., Wang, X., & Zhu, X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.014 · Cited by 718
Mitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 677
Repression of α-synuclein expression and toxicity by microRNA-7
Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 634
Self-citationJiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 605
Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics
Irrcher, I., Aleyasin, H., Seifert, E. L., Hewitt, S. J., Chhabra, S., Phillips, M., Lutz, A. K., Rousseaux, M. W. C., Bevilacqua, L., Jahani‐Asl, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq288 · Cited by 394
Neuroprotective Function of DJ-1 in Parkinson’s Disease
Ariga, H., Takahashi-Niki, K., Kato, I., Maita, H., Niki, T., & Iguchi-Ariga, S. M. M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/683920 · Cited by 373
Krebiehl, G., Ruckerbauer, S., Burbulla, L. F., Kieper, N., Maurer, B., Waak, J., Wolburg, H., Gizatullina, Z. Z., Gellerich, F. N., Woitalla, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009367 · Cited by 381
Mitochondrial Quality Control and Disease: Insights into Ischemia-Reperfusion Injury
Anzell, A. R., Maizy, R., Przyklenk, K., & Sanderson, T. H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0503-9 · Cited by 359
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
Büeler, H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.006 · Cited by 332
The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms
Kang, I., Chu, C. T., & Kaufman, B. A. (2018) · FEBS Letters · doi:10.1002/1873-3468.12989 · Cited by 334
DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders
Kahle, P. J., Waak, J., & Gasser, T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.08.003 · Cited by 324
The Role of Cysteine Oxidation in DJ-1 Function and Dysfunction
Wilson, M. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3481 · Cited by 304
Blackinton, J. G., Lakshminarasimhan, M., Craig, K. J. T., Ahmad, R., Greggio, E., Raza, A. S., Cookson, M., & Wilson, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806599200 · Cited by 279
Absence of nigral degeneration in aged parkin/DJ‐1/PINK1 triple knockout mice
Kitada, T., Tong, Y., Gautier, C., & Shen, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06350.x · Cited by 271
Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease
Dolgacheva, L. P., Berezhnov, A. V., Fedotova, E. I., Zinchenko, V. P., & Abramov, A. Y. (2019) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-019-09798-4 · Cited by 254
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 262
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
Higgins, G. C., & Coughlan, M. T. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12503 · Cited by 257
Urrutia, P. J., Mena, N. P., & NÃoñez, M. T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00038 · Cited by 244
Mitophagy and Parkinson's disease: The PINK1–parkin link
Deas, E., Wood, N. W., & Plun‐Favreau, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.007 · Cited by 230
Oxidative stress factors in Parkinson’s disease
Dorszewska, J., Kowalska, M., Prendecki, M., Piekut, T., Kozłowska, J., & Kozubski, W. P. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300980 · Cited by 217
Wang, X., Petrie, T. G., Liu, Y., Liu, J., Fujioka, H., & Zhu, X. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07734.x · Cited by 217
ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons
Joselin, A. P., Hewitt, S. J., Callaghan, S. M., Kim, R. H., Chung, Y.-H., Mak, T. W., Shen, J., Slack, R. S., & Park, D. S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds325 · Cited by 205
Ottolini, D., Calí, T., Negro, A., & Brini, M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt068 · Cited by 210
DJ-1 binds to mitochondrial complex I and maintains its activity
Hayashi, T., Ishimori, C., Takahashi-Niki, K., Taira, T., Kim, Y.-C., Maita, H., Maita, C., Ariga, H., & Iguchi‐Ariga, S. M. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.025 · Cited by 199
Zhou, W., Bercury, K. K., Cummiskey, J., Luong, N., Lebin, J. A., & Freed, C. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211029 · Cited by 183
Salivary biomarkers for the diagnosis and monitoring of neurological diseases
Farah, R., Haraty, H., Salame, Z., Fares, Y., Ojcius, D. M., & Sadier, N. S. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.03.004 · Cited by 175
Parkinson's disease: insights from pathways
Cookson, M., & Bandmann, O. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq167 · Cited by 166
DJ-1 is an essential downstream mediator in PINK1/parkin-dependent mitophagy
Imberechts, D., Kinnart, I., Wauters, F., Terbeek, J., Manders, L., Wierda, K. D. B., Eggermont, K., Madeiro, R. F., Sue, C. M., Verfaillie, C. M., et al. (2022) · Brain · doi:10.1093/brain/awac313 · Cited by 168
Gagaoua, M., Terlouw, C. E. M., Mullen, A. M., Franco, D., Warner, R. D., Lorenzo, J. M., Purslow, P. P., Gerrard, D. E., Hopkins, D. L., TROY, D. J., et al. (2020) · Meat Science · doi:10.1016/j.meatsci.2020.108311 · Cited by 158
Mitochondrial Contribution to Parkinson's Disease Pathogenesis
Schapira, A. H. V., & Gegg, M. E. (2011) · Parkinson s Disease · doi:10.4061/2011/159160 · Cited by 155
Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases
Weng, T.-Y., Tsai, S., & Su, T. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0380-6 · Cited by 142
Burbulla, L. F., Schelling, C., Kato, H., Rapaport, D., Woitalla, D., Schiesling, C., Schulte, C., Sharma, M., Illig, T., Bauer, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq370 · Cited by 137
Moghadam, A. K., Charsouei, S., Bell, B., & Jabalameli, M. R. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0587-4 · Cited by 143
Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
Calí, T., Ottolini, D., & Brini, M. (2011) · BioFactors · doi:10.1002/biof.159 · Cited by 138
The Parkinson’s-associated protein DJ-1 regulates the 20S proteasome
Moscovitz, O., Ben‐Nissan, G., Fainer, I., Pollack, D., Mizrachi, L., & Sharon, M. (2015) · Nature Communications · doi:10.1038/ncomms7609 · Cited by 130
Milani, P., Ambrosi, G., Gammoh, O. S., Blandini, F., & Cereda, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/836760 · Cited by 128
Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease
Plotegher, N., & Duchen, M. R. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00110 · Cited by 106
DJ-1 as a human oncogene and potential therapeutic target
Cao, J., Lou, S., Ying, M., & Yang, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.012 · Cited by 117
Synapses in neurodegenerative diseases
Bae, J. R., & Kim, S. H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.5.038 · Cited by 122
Weng, M., Xie, X., Liu, C., Lim, K., Zhang, C., & Li, L. (2018) · Parkinson s Disease · doi:10.1155/2018/9163040 · Cited by 117
The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation
Xu, X. M., Lin, H., Maple‐Grødem, J., Björkblom, B., Alves, G. W., Larsen, J. P., & Møller, S. G. (2010) · Journal of Cell Science · doi:10.1242/jcs.063222 · Cited by 109
Mitochondrial fission and fusion in secondary brain damage after CNS insults
Balog, J., Mehta, S. L., & Vemuganti, R. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16671528 · Cited by 110
Proteomic biomarkers of beef colour
Gagaoua, M., Hughes, J. M., Terlouw, C. E. M., Warner, R. D., Purslow, P. P., Lorenzo, J. M., & Picard, B. B. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.05.005 · Cited by 107
Pathogenesis of DJ-1/PARK7-Mediated Parkinson’s Disease
Skou, L. D., Johansen, S. K., Okarmus, J., & Meyer, M. (2024) · Cells · doi:10.3390/cells13040296 · Cited by 120
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 106
Drosophila as a Model to Study Mitochondrial Dysfunction in Parkinson's DiseasePreprint
Guo, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009944 · Cited by 111
Role of DJ-1 in Immune and Inflammatory Diseases
Zhang, L., Wang, J., Wang, J., Yang, B., He, Q., & Weng, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00994 · Cited by 110
Chen, R., Park, H., Mnatsakanyan, N., Niu, Y., Licznerski, P., Wu, J., Miranda, P., Graham, M. M., Tang, J., Boon, A. J. W., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1679-x · Cited by 97
Barrera, G., Gentile, F., Pizzimenti, S., Canuto, R. A., Daga, M., Arcaro, A., Cetrangolo, G. P., Lepore, A., Ferretti, C., Dianzani, C., et al. (2016) · Antioxidants · doi:10.3390/antiox5010007 · Cited by 98
Helley, M., Pinnell, J. R., Sportelli, C., & Tieu, K. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00177 · Cited by 98
Miranda, B. R. D., Rocha, E. M., Bai, Q., Ayadi, A. E., Hinkle, D., Burton, E. A., & Greenamyre, J. T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.008 · Cited by 99
Giaime, E., Yamaguchi, H., Gautier, C., Kitada, T., & Shen, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040501 · Cited by 94
DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex
Im, J., Lee, K.-W., Junn, E., & Mouradian, M. M. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.04.002 · Cited by 94
Self-citationOh, S. E., Park, H.-J., He, L., Skibiel, C., Junn, E., & Mouradian, M. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.021 · Cited by 92
Self-citationBiochemical and cellular basis of oxidative stress: Implications for disease onset
Aramouni, K., Assaf, R., Shaito, A. A., Fardoun, M., Al‐Asmakh, M., Sahebkar, A., & Eid, A. H. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31071 · Cited by 97
Saito, Y., Hamakubo, T., Yoshida, Y., Ogawa, Y., Hara, Y., Fujimura, H., Imai, Y., Iwanari, H., Mochizuki, Y., Shichiri, M., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.074 · Cited by 87
DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application
Huang, M., & Chen, S. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102114 · Cited by 88
Mitochondrial quality control and neurological disease: an emerging connection
de Castro, I. P., Martins, L. M., & Tufi, R. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001456 · Cited by 92
Parkinson's disease and age: The obvious but largely unexplored link
Abdullah, R., Basak, I., Patil, K. S., Alves, G. W., Larsen, J. P., & Møller, S. G. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.014 · Cited by 87
PGC-1s in the Spotlight with Parkinson’s Disease
Piccinin, E., Sardanelli, A. M., Seibel, P., Moschetta, A., Cocco, T., & Villani, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073487 · Cited by 85
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 87
Mitochondrial control of cell bioenergetics in Parkinson’s disease
Requejo-Aguilar, R., & Bolaños, J. P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.012 · Cited by 87
Oxidized DJ-1 Interacts with the Mitochondrial Protein BCL-XL
Ren, H., Fu, K., Wang, D., Mu, C., & Wang, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.207134 · Cited by 80
Chan, J. Y. H., & Chan, S. H. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.09.005 · Cited by 75
Mnatsakanyan, N., & Jonas, E. A. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.05.013 · Cited by 76
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
Mogensen, F. L., Scafidi, A., Poli, A., & Michelucci, A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02776-z · Cited by 80
SUMO ‐regulated mitochondrial function in Parkinson's disease
Souza, A. C. G., Prediger, R. D., & Cimarosti, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13599 · Cited by 78
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
Mukherjee, U., Ong, S., Ong, S., & Hausenloy, D. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.005 · Cited by 72
Smolders, S., & Broeckhoven, C. V. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00935-4 · Cited by 72
Tai-Nagara, I., Matsuoka, S., Ariga, H., & Suda, T. (2013) · Blood · doi:10.1182/blood-2013-06-508333 · Cited by 71
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A., & Nash, J. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15154 · Cited by 74
Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease
Guerra, F., Girolimetti, G., Beli, R., Mitruccio, M., Pacelli, C., Ferretta, A., Gasparre, G., Cocco, T., & Bucci, C. (2019) · Cells · doi:10.3390/cells8050452 · Cited by 66
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
Lazzari, F. D., Bubacco, L., Whitworth, A. J., & Bisaglia, M. (2018) · Aging and Disease · doi:10.14336/ad.2017.1018 · Cited by 66
Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death
Kim, S., Park, Y.-J., Hwang, I.-Y., Youdim, M. B. H., Park, K., & Oh, Y. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.035 · Cited by 66
Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease
Burbulla, L. F., & Krüger, R. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.005 · Cited by 65
Functional Aspects of Redox Control During Neuroinflammation
Rosales‐Corral, S., Reiter, R. J., Tan, D., Ortiz, G. G., & López-Armas, G. D. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2629 · Cited by 66
Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson’s Disease
Bej, E., Cesare, P., Volpe, A. R., d’Angelo, M., & Castelli, V. (2024) · Neurology International · doi:10.3390/neurolint16030037 · Cited by 74
Wilhelmus, M. M. M., Nijland, P. G., Drukarch, B., de Vries, H. E., & van Horssen, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.040 · Cited by 62
Cross talk between two antioxidant systems, Thioredoxin and DJ-1: consequences for cancer
Raninga, P. V., Trapani, G. D., & Tonissen, K. F. (2014) · Oncoscience · doi:10.18632/oncoscience.12 · Cited by 63
The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease
Mencke, P., Boussaad, I., Romano, C., Kitami, T., Linster, C. L., & Krüger, R. (2021) · Cells · doi:10.3390/cells10020347 · Cited by 64
Dewapriya, P., Himaya, S. W. A., Li, Y.-X., & Kim, S. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.04.004 · Cited by 60
The Succinated Proteome of FH-Mutant Tumours
Yang, M. H., Ternette, N., Su, H., Dabiri, R., Kessler, B. M., Adam, J., Teh, B. T., & Pollard, P. J. (2014) · Metabolites · doi:10.3390/metabo4030640 · Cited by 60
Toyoda, Y., Erkut, C., Pan-Montojo, F. J., Boland, S., Stewart, M. P., Müller, D. J., Wurst, W., Hyman, A. A., & Kurzchalia, T. V. (2014) · Biology Open · doi:10.1242/bio.20149399 · Cited by 61
Ahlskog, J. E. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.09.010 · Cited by 59
Wang, W., Zhao, H., & Chen, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-59408-2 · Cited by 57
Huang, Y., Driedonks, T. A. P., Cheng, L., Turchinovich, A., Rajapaksha, H., Arab, T., Powell, B. H., Pletniková, O., Redding‐Ochoa, J., Troncoso, J. C., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220322 · Cited by 58
The Parkinson's disease-related genes act in mitochondrial homeostasis
Sai, Y., Zou, Z., Peng, K., & Dong, Z. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.06.007 · Cited by 55
Bonilha, V. L., Bell, B. A., Rayborn, M. E., Yang, X., Kaul, C., Grossman, G. H., Samuels, I. S., Hollyfield, J. G., Xie, C., Cai, H., et al. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.014 · Cited by 55
Protection of Pancreatic β-Cells from Various Stress Conditions Is Mediated by DJ-1
Inberg, A., & Michal Linial, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109751 · Cited by 55
Feng, C., Hung, H.-C., Huang, S., Chen, C., Chen, Y., Chen, C.-Y., Yang, S., Wang, H.-M. D., Sung, P., Sheu, J., et al. (2016) · Marine Drugs · doi:10.3390/md14100187 · Cited by 55
The relevant targets of anti-oxidative stress: a review
Qi, J., & Dong, F.-X. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2020.1870987 · Cited by 54
Lopert, P., & Patel, M. (2014) · Redox Biology · doi:10.1016/j.redox.2014.04.010 · Cited by 52
Metadata
- Authors
- Junn, E., Jang, W. H., Zhao, X., Jeong, B. S., & Mouradian, M. M.
- Affiliations
- Inje University (KR)
- Corresponding author
- Mouradian, M. Maral
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2008-08-18
- Volume
- 87
- Issue
- 1
- Pages
- 123-129
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- PMC
- PMC2752655
- OpenAlex
- W2143048992
- Cited by
- 320
- References
- 43
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 12 · 2023: 18 · 2022: 21 · 2021: 24 · 2020: 19 · 2019: 16 · 2018: 23 · 2017: 16 · 2016: 18 · 2015: 10 · 2014: 24 · 2013: 23 · 2012: 19
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS053517, R01NS059869, NS059869, R21NS053517)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- DJ-1, Parkinson's disease, mitochondrial localization, subcellular compartmentalization, oxidative stress, neuroprotection, protein dimerization, antioxidant activity, nuclear translocation, cysteine modification, dopaminergic neurons
- MeSH terms
- Protein Deglycase DJ-1, Analysis of Variance, Cell Nucleus, Cysteine, Humans, Hydrogen Peroxide, Mitochondria, Mutation, Neuroblastoma, Transfection, Oncogene Proteins, Oxidants, Cell Death, Apoptosis, Neuroprotective Agents, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review